Tus kws kho mob
P11-22 Billing Changes for Residential Treatment Centers and 1115 Waiver Providers for Minnesota Health Care Programs
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1851 - 1860 ntawm 3685
Tus kws kho mob
P12-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates - Effective May 2, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P13-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2022
Tus kws kho mob
QP17-22 Commercial Pharmacy Benefit Exclusion for Vabysmo™ and Xipere™
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 09, 2022
Tus kws kho mob
QP18-22 Minnesota Health Care Programs Housing Stabilization Referrals
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 09, 2022
Tus kws kho mob
QP19-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective May 1, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 09, 2022
Tus kws kho mob
2022 March Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2022
Tus kws kho mob
Tavneos™ (avacopan) - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
Opzelura™ (ruxolitinib) - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 01, 2024
Tus kws kho mob
QP22-22 Second Opinion Pilot for Select MSK Procedures Available to Commercial Fully Insured and Individual Members
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 09, 2022